Drug class

Peripheral Adrenolytics

"Peripheral Adrenolytics" is an obsolete pharmacologic term corresponding to modern peripherally acting antiadrenergic agents, which encompass peripheral alpha-adrenergic receptor antagonists and postganglionic adrenergic neuron blockers. Read more about Peripheral Adrenolytics

144 drugs in this class 71 manufacturers

Advertisement

Drugs in Peripheral Adrenolytics

Showing 46–54 of 144 drugs

FLOMAX (tamsulosin HCl)

ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
Boehringer Ingelheim

PHENTOLAMINE MESYLATE

ALPHA-BLOCKERS · DIAGNOSTIC TEST FOR PHEOCHROMOCYTOMA ·+2
Hikma Pharmaceuticals USA

PRAZOSIN HCL

ALPHA-BLOCKERS · HYPERTENSION
GSK Consumer Healthcare

SILODOSIN

ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
AJANTA PHARMA L

SILODOSIN

ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
MACLEODS PHARMA

SILODOSIN

ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
AUROBINDO PHARM

SILODOSIN

ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
LUPIN PHARMACEU
Filter & compare in the drug finder → Opens the drug finder with Peripheral Adrenolytics preselected. Add indication or manufacturer filters there.

About Peripheral Adrenolytics.

"Peripheral Adrenolytics" is an obsolete pharmacologic term corresponding to modern peripherally acting antiadrenergic agents, which encompass peripheral alpha-adrenergic receptor antagonists and postganglionic adrenergic neuron blockers.

These agents function in the peripheral nervous system by directly antagonizing alpha-adrenoceptors or inhibiting peripheral norepinephrine release, thereby blocking sympathetic vasoconstriction and lowering systemic vascular resistance.

Clinically, drugs within this therapeutic category have historically been utilized in cardiovascular and urological medicine to manage essential hypertension, hypertensive crises, and lower urinary tract symptoms associated with benign prostatic hyperplasia.